Terms: = Lymphoma AND FGFR2, BFR-1, 2263, ENSG00000066468, TK14, BEK, CD332, JWS, TK25, ECT1, CEK3, K-SAM, CFD1, KGFR AND Treatment
14 results:
1. NGS-based liquid biopsy profiling identifies mechanisms of resistance to ALK inhibitors: a step toward personalized NSCLC treatment.
Sánchez-Herrero E; Serna-Blasco R; Ivanchuk V; García-Campelo R; Dómine Gómez M; Sánchez JM; Massutí B; Reguart N; Camps C; Sanz-Moreno S; Calabuig-Fariñas S; Jantus-Lewintre E; Arnal M; Fernández-Orth D; Calvo V; González-Rumayor V; Provencio M; Romero A
Mol Oncol; 2021 Sep; 15(9):2363-2376. PubMed ID: 34058070
[TBL] [Abstract] [Full Text] [Related]
2. Erdafitinib as a Novel and Advanced treatment Strategy of Metastatic Urothelial Carcinoma.
Bansal P; Dwivedi DK; Hatwal D; Sharma P; Gupta V; Goyal S; Maithani M
Anticancer Agents Med Chem; 2021; 21(18):2478-2486. PubMed ID: 33475078
[TBL] [Abstract] [Full Text] [Related]
3. Analysis of Bone Tissue Condition in Patients with Diffuse Large B-Cell lymphoma without Bone Marrow Involvement.
Fastova EA; Magomedova AU; Kravchenko SK; Petinati NA; Sats NV; Drize NI; Savchenko VG
Bull Exp Biol Med; 2020 Sep; 169(5):677-682. PubMed ID: 32986209
[TBL] [Abstract] [Full Text] [Related]
4. Erdafitinib: First Global Approval.
Markham A
Drugs; 2019 Jun; 79(9):1017-1021. PubMed ID: 31161538
[TBL] [Abstract] [Full Text] [Related]
5. The efficacy of cisplatin on nasopharyngeal carcinoma cells may be increased via the downregulation of fibroblast growth factor receptor 2.
Pu L; Su L; Kang X
Int J Mol Med; 2019 Jul; 44(1):57-66. PubMed ID: 31115494
[TBL] [Abstract] [Full Text] [Related]
6. Patterns of care in Jehovah's Witnesses patients with solid tumours and lymphoma.
Chang Lee R; Sukumaran S; Koczwara B; Woodman R; Kichenadasse G; Roy A; Vatandoust S; Karapetis C
Cancer Rep (Hoboken); 2019 Apr; 2(2):e1148. PubMed ID: 32721085
[TBL] [Abstract] [Full Text] [Related]
7. Alterations in multipotent mesenchymal stromal cells from the bone marrow of acute myeloid leukemia patients at diagnosis and during treatment.
Shipounova IN; Petinati NA; Bigildeev AE; Sorokina TV; Kuzmina LA; Parovichnikova EN; Savchenko VG
Leuk Lymphoma; 2019 Aug; 60(8):2042-2049. PubMed ID: 30668205
[TBL] [Abstract] [Full Text] [Related]
8. A randomized, open-label study of the efficacy and safety of AZD4547 monotherapy versus paclitaxel for the treatment of advanced gastric adenocarcinoma with fgfr2 polysomy or gene amplification.
Van Cutsem E; Bang YJ; Mansoor W; Petty RD; Chao Y; Cunningham D; Ferry DR; Smith NR; Frewer P; Ratnayake J; Stockman PK; Kilgour E; Landers D
Ann Oncol; 2017 Jun; 28(6):1316-1324. PubMed ID: 29177434
[TBL] [Abstract] [Full Text] [Related]
9. Autologous Stem-Cell Transplantation Without Hematopoietic Support for the treatment of Hematologic Malignancies in Jehovah's Witnesses.
Ford PA; Grant SJ; Mick R; Keck G
J Clin Oncol; 2015 May; 33(15):1674-9. PubMed ID: 25870085
[TBL] [Abstract] [Full Text] [Related]
10. FGF receptors: cancer biology and therapeutics.
Katoh M; Nakagama H
Med Res Rev; 2014 Mar; 34(2):280-300. PubMed ID: 23696246
[TBL] [Abstract] [Full Text] [Related]
11. Allogeneic stem cell transplantation for patients with relapsed chemorefractory aggressive non-hodgkin lymphomas.
Hamadani M; Benson DM; Hofmeister CC; Elder P; Blum W; Porcu P; Garzon R; Blum KA; Lin TS; Marcucci G; Devine SM
Biol Blood Marrow Transplant; 2009 May; 15(5):547-53. PubMed ID: 19361746
[TBL] [Abstract] [Full Text] [Related]
12. The expression of fibroblast growth factors and their receptors in Hodgkin's lymphoma.
Khnykin D; Troen G; Berner JM; Delabie J
J Pathol; 2006 Feb; 208(3):431-8. PubMed ID: 16353171
[TBL] [Abstract] [Full Text] [Related]
13. Immunodeficiency and Hodgkin's disease: treatment and outcome in the DAL HD78-90 and GPOH HD95 studies.
Niehues T; Schellong G; Dörffel W; Bucsky P; Mann G; Körholz D; Göbel U
Klin Padiatr; 2003; 215(6):315-20. PubMed ID: 14677095
[TBL] [Abstract] [Full Text] [Related]
14. k-sam-related gene, N-sam, encodes fibroblast growth factor receptor and is expressed in T-lymphocytic tumors.
Hattori Y; Odagiri H; Katoh O; Sakamoto H; Morita T; Shimotohno K; Tobinai K; Sugimura T; Terada M
Cancer Res; 1992 Jun; 52(12):3367-71. PubMed ID: 1317750
[TBL] [Abstract] [Full Text] [Related]
